|
|
Current Uses

Testimonials

Case Studies

FAQs

Safety
We're so glad Sadie was chosen for a part in the Vet-Stem research
project. She's doing so much better, getting up steps great, and even getting on her brother's bed unassisted! She's in much
greater spirits and really
enjoyed her walk with us around the cotton fields. You helped a "miracle" happen! Thanks.
Sharon
Raynor Tarboro, NC

|
|

Equine tendon, ligament, and joint injuries are some of the most frequently seen and the most debilitating in clinical veterinary practice leading to joint instability, degenerative joint disease, and reduced performance. Traditional therapies address the inflammatory process and pain, yet have not successfully addressed the regeneration of these tissues that often result in scar tissue formation and partial or full loss of function. Whether these horses are performance athletes or companions, their owners are seeking therapy that can return them to their chosen level of activity.
With more than 3,000 horses treated and multiple studies3-6 demonstrating the success and safety of Vet-Stem
regenerative
medicine, Vet-Stem has the technology and the experience to help horses with fractures, joint disease, or tendon or ligament injuries return to their full level of ability.
Why Vet-Stem regenerative medicine for your horse?
- More than 3,000 horses treated for:
- Tendon injury: acute and chronic
- Ligament injury: suspensory, check, collaterals-acute and chronic
- Joints: osteoarthritis, osteochondral defects
- Demonstrated efficacy in scientific studies 3-6
- Demonstrated significant improvement in tendons at the cellular level1
- Successful case studies3,4
- Safe with no significant adverse events reported6
- Vet-Stem cell therapy is limited to use by licensed veterinarians.
|
Multiple studies demonstrated the efficacy of VSRC therapy:
- Suspensory ligament injury: 76% (47/62) returned to full work at the prior level.4
- Joint disease: 56.7% (34/60) returned to full work at prior level and 26.7% (16/60) returned to full work at a reduced level.3
- Return to performance survey: 89% return to performance in 179 non-race horses with either joint, tendon, or ligament injuries.4
|
|